Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaker R Dakhil

Showing results (11-20 of 114) with videos related to

Pageof 12
Sort By:
Cancer|June 17, 2006
A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007Francis P Worden, James Moon, Wolfram Samlowski, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 6, 2011
Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patientsJulie L Ryan, Charles E Heckler, Joseph A Roscoe, et al.
Clinical Lymphoma|April 4, 2003
Pegylated liposomal doxorubicin as single-agent treatment of low-grade non-Hodgkin's lymphoma: a phase II multicenter studyNicholas J Di Bella, Myrna M Khan, Shaker R Dakhil, et al.
Clinical Prostate Cancer|October 14, 2004
Phase II randomized trial of weekly paclitaxel with or without estramustine phosphate in progressive, metastatic, hormone-refractory prostate cancerWilliam R Berry, James W Hathorn, Shaker R Dakhil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2013
Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance)Charles L Loprinzi, Rui Qin, Shaker R Dakhil, et al.
Investigational New Drugs|May 4, 2005
Phase II trial of dolastatin-10 in patients with advanced breast cancerEdith A Perez, David W Hillman, Paul A Fishkin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 24, 2015
Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy: a 5-year follow-upNeil Majithia, Pamela J Atherton, Jacqueline M Lafky, et al.
Menopause (New York, N.Y.)|April 23, 2008
Mayo Clinic and North Central Cancer Treatment Group hot flash studies: a 20-year experienceCharles L Loprinzi, Debra L Barton, Jeff A Sloan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 28, 2004
Investigating the utility of serum cytokine measurements in a multi-institutional cancer anorexia/weight loss trialAminah Jatoi, James Egner, Charles L Loprinzi, et al.
The Lancet. Oncology|October 4, 2005
5-Hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trialJane T Hickok, Joseph A Roscoe, Gary R Morrow, et al.
Pageof 12

Showing results (11-20 of 114) with videos related to

Sort By:
Pageof 12
Cancer|June 17, 2006
A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007Francis P Worden, James Moon, Wolfram Samlowski, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 6, 2011
Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patientsJulie L Ryan, Charles E Heckler, Joseph A Roscoe, et al.
Clinical Lymphoma|April 4, 2003
Pegylated liposomal doxorubicin as single-agent treatment of low-grade non-Hodgkin's lymphoma: a phase II multicenter studyNicholas J Di Bella, Myrna M Khan, Shaker R Dakhil, et al.
Clinical Prostate Cancer|October 14, 2004
Phase II randomized trial of weekly paclitaxel with or without estramustine phosphate in progressive, metastatic, hormone-refractory prostate cancerWilliam R Berry, James W Hathorn, Shaker R Dakhil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2013
Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance)Charles L Loprinzi, Rui Qin, Shaker R Dakhil, et al.
Investigational New Drugs|May 4, 2005
Phase II trial of dolastatin-10 in patients with advanced breast cancerEdith A Perez, David W Hillman, Paul A Fishkin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 24, 2015
Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy: a 5-year follow-upNeil Majithia, Pamela J Atherton, Jacqueline M Lafky, et al.
Menopause (New York, N.Y.)|April 23, 2008
Mayo Clinic and North Central Cancer Treatment Group hot flash studies: a 20-year experienceCharles L Loprinzi, Debra L Barton, Jeff A Sloan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 28, 2004
Investigating the utility of serum cytokine measurements in a multi-institutional cancer anorexia/weight loss trialAminah Jatoi, James Egner, Charles L Loprinzi, et al.
The Lancet. Oncology|October 4, 2005
5-Hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trialJane T Hickok, Joseph A Roscoe, Gary R Morrow, et al.
Pageof 12